Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Clopidogrel is an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease and such arterial or vascular associated disorders. The pharmacokinetics study of Clopidogrel active metabolite and its antiplatelet effects are measured by ex vivo platelet aggregation assays.
Journals Related to Clopidogrel Pharmacokinetics:
Journal of Pharmacokinetics & Experimental Therapeutics, International Journal of Drug Development and Research, Physiobiochemical Metabolism, Journal of Pharmacokinetics and Pharmacodynamics, Journal of Drug metabolism & Toxicology, Journal of Drug metabolism & Toxicology.